Stocks in play: Aritzia Inc.
Today announced that, in connection with its previously announced normal course issuer bid ("NCIB") to purchase up to 3,860,745 of its subordinate voting shares during the 12-month period beginning January 20, 2023 and ending January 19, 2024, it has entered into an automatic share purchase plan with its designated broker. The ASPP is intended to allow for the purchase of Shares under the NCIB during pre-determined times when Aritzia would ordinarily not be permitted to purchase Shares due to regulatory restrictions and customary blackout periods. Aritzia Inc. shares T.ATZ are trading down $0.12 at $47.60.
Read:
Addressing the USA’s 200 to 1 Security Protection Gap is a Serious Concern for Tech Companies
Latest Set of FDA Fast Track Designations Causing Optimism in Biotech Sector
Biotech Sector to Unveil New Data and Developments at 2022 SABCS in San Antonio
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
New Biotech Sector Drug Combinations Target a Drop in Pancreatic Cancer Mortality Rates